Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Brett Case

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Cell Host & Microbe|August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Nature Microbiology|October 15, 2025
The IFIT2-IFIT3 antiviral complex targets short 5' untranslated regions on viral mRNAs for translation inhibitionDustin R Glasner, Candace Todd, Brian Cook, et al.
Journal of Molecular Biology|July 30, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
SSRN|July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2020
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusionRuochen Zang, James Brett Case, Eylan Yutuc, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Cell Host & Microbe|August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Nature Microbiology|October 15, 2025
The IFIT2-IFIT3 antiviral complex targets short 5' untranslated regions on viral mRNAs for translation inhibitionDustin R Glasner, Candace Todd, Brian Cook, et al.
Journal of Molecular Biology|July 30, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
SSRN|July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2020
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusionRuochen Zang, James Brett Case, Eylan Yutuc, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Pageof 9